ACTIVATING POINT MUTATIONS IN THE COMMON BETA-SUBUNIT OF THE HUMAN GM-CSF, IL-3 AND IL-5 RECEPTORS SUGGEST THE INVOLVEMENT OF BETA-SUBUNIT DIMERIZATION AND CELL-TYPE-SPECIFIC MOLECULES IN SIGNALING

被引:77
作者
JENKINS, BJ
DANDREA, R
GONDA, TJ
机构
[1] INST MED & VET SCI, HANSON CTR CANC RES, ADELAIDE, SA 5000, AUSTRALIA
[2] INST MED & VET SCI, DIV HUMAN IMMUNOL, ADELAIDE, SA 5000, AUSTRALIA
关键词
CYTOKINE RECEPTOR SUPERFAMILY; HUMAN GM-CSF RECEPTOR COMMON BETA CHAIN; ONCOGENIC ACTIVATION; POLYMERASE CHAIN REACTION MUTAGENESIS; RETROVIRAL EXPRESSION CLONING;
D O I
10.1002/j.1460-2075.1995.tb00102.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have combined retroviral expression cloning with random mutagenesis to identify two activating point mutations in the common signal-transducing subunit (h beta c) of the receptors for human granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-5 by virtue of their ability to confer factor independence on the haemopoietic cell line, FDC-P1. One mutation (V449E) is located within the transmembrane domain and, by analogy with a similar mutation in the neu oncogene, may act by inducing dimerization of h beta c. The other mutation (I374N) lies in the extracellular, membrane-proximal portion of h beta c. Neither of these mutants, nor a previously described mutant of h beta c (FI Delta, which has a small duplication in the extracellular region), was capable of inducing factor independence in CTLL-2 cells, while only V449E could induce factor independence in BAF-B03 cells. These results imply that the extracellular and transmembrane mutations act by different mechanisms. Furthermore, they imply that the mutants, and hence also wild-type h beta c, interact with cell type-specific signalling molecules. Models are presented which illustrate how these mutations may act and predict some of the characteristics of the putative receptor-associated signalling molecules.
引用
收藏
页码:4276 / 4287
页数:12
相关论文
共 69 条
[1]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[2]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[3]  
BARRY SC, 1994, J BIOL CHEM, V269, P8488
[5]   CORRELATION OF THE STRUCTURE OF THE TRANSMEMBRANE DOMAIN OF THE NEU ONCOGENE-ENCODED P185 PROTEIN WITH ITS FUNCTION [J].
BRANDTRAUF, PW ;
RACKOVSKY, S ;
PINCUS, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8660-8664
[6]  
BROWN MA, 1993, LEUKEMIA, V7, P63
[7]  
Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28
[8]   A SUBDOMAIN IN THE TRANSMEMBRANE DOMAIN IS NECESSARY FOR P185NEU-STAR ACTIVATION [J].
CAO, H ;
BANGALORE, L ;
BORMANN, BJ ;
STERN, DF .
EMBO JOURNAL, 1992, 11 (03) :923-932
[9]   GENERATION OF CYTOTOXIC T LYMPHOCYTES INVITRO .1. RESPONSE OF NORMAL AND IMMUNE MOUSE SPLEEN-CELLS IN MIXED LEUKOCYTE-CULTURES [J].
CEROTTINI, JC ;
ENGERS, HD ;
MACDONALD, HR ;
BRUNNER, KT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (03) :703-717
[10]   THE HUMAN HEMATOPOIETIC COLONY-STIMULATING FACTORS [J].
CLARK, SC ;
KAMEN, R .
SCIENCE, 1987, 236 (4806) :1229-1237